The accelerated approval of oncologic drugs: lessons from ponatinib. Academic Article uri icon

Overview

publication date

  • January 1, 2014

Research

keywords

  • Antineoplastic Agents
  • Drug Approval
  • Imidazoles
  • Pyridazines

Identity

Scopus Document Identifier

  • 84892701195

Digital Object Identifier (DOI)

  • 10.1001/jama.2013.284531

PubMed ID

  • 24449310

Additional Document Info

volume

  • 311

issue

  • 4